F. Busch

发表

Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism.

M. Eichelbaum, H. Kroemer, D. Busse, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside

G. Pawelec, A. Rehbein, H. Schmidt, 2004, Cancer Immunology, Immunotherapy.

Differential secretion of tumor necrosis factor‐α and granulocyte/macrophage colony‐stimulating factors but not interferon‐γ from CD4 compared to CD8 human T cell clones

G. Pawelec, A. Rehbein, K. Schaudt, 1989, European journal of immunology.

Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow.

A. Saalmüller, M. Letarte, H. Bühring, 1991, Leukemia.

Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon α

G. Pawelec, A. Rehbein, F. Busch, 2005, Cancer Immunology, Immunotherapy.

Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolism

M. Eichelbaum, H. Kroemer, D. Busse, 1999, Cancer Chemotherapy and Pharmacology.

Prevention of human helper T-cell clone activation by cyclosporin A also blocks secretion of granulocyte/macrophage colony stimulating activity.

G. Pawelec, A. Rehbein, I. Balko, 1988, Immunopharmacology.

Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-α-treated chronic myelogenous leukaemia patients

G. Pawelec, G. Ehninger, H. Bühring, 2005, Cancer Immunology, Immunotherapy.

HLA-class II antigens on human hematopoietic progenitors

P. Wernet, G. Pawelec, A. Ziegler, 1987, Blut.

Different signals for stimulation of proliferation and lymphokine secretion by a CD3+ WT31- cloned cytotoxic lymphocyte.

P. Wernet, G. Pawelec, F. Kalthoff, 1988, Cellular immunology.

Sequential expression of CD34 and CD33 antigens on myeloid colony‐forming cells

B. Asenbauer, H. Bühring, F. Busch, 1989, European journal of haematology.

The Receptor Tyrosine Kinase ~ 1 8 5 ~ ~ ~ ~ Is Expressed on a Subset of B-Lymphoid Blasts Prom Patients With Acute Lymphoblastic Leukemia and Chronic Myelogenous Leukemia

W. Ludwig, B. Jallal, R. Handgretinger, 2002 .

The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.

A. Ullrich, W. Ludwig, B. Jallal, 1995, Blood.

Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial.

T. Lipp, A. Ganser, M. Kneba, 1995, Blood.

Hepatitis A: hepatotropism and influence on myelopoiesis.

A. Vallbracht, F. Busch, B. Fleischer, 1993, Intervirology.

Selective inhibition of interleukin 2 but not of interferon-gamma, tumour necrosis factor-alpha or granulocyte/macrophage colony stimulating factor secretion by human helper T cell clones after antigen-driven tolerisation.

G. Pawelec, T. Sayers, F. Busch, 1989, Immunology letters.

Acquisition of suppressive and natural killer-like activities associated with loss of alloreactivity in human "helper" T-lymphocyte clones.

P. Wernet, G. Pawelec, E. Schneider, 1986, Current topics in microbiology and immunology.

Regulation of normal myelopoiesis and chronic myelogenous leukaemia' cell proliferation through a non-cytotoxic mechanism by a γ/δ T cell clone

G. Pawelec, T. Sayers, F. Busch, 1989 .

Myelopoiesis in vitro is suppressed by hepatitis A virus

G. Pawelec, H. Mergenthaler, B. Flehmig, 2005, Annals of Hematology.

The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes

E. Becker, M. Owsianowski, P. Berg, 2004, European Journal of Clinical Pharmacology.

The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.

A. Ullrich, H. Bühring, C. Müller, 1991, Leukemia.

Inhibition of in vitro hematopoiesis by hepatitis A virus.

S. de Vos, F. Herrmann, B. Flehmig, 1987, Experimental hematology.

Pharmacokinetics of intravenous etoposide in patients with breast cancer: influence of dose escalation and cyclophosphamide and doxorubicin coadministration

M. Fromm, M. Eichelbaum, H. Kroemer, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Hemophagocytic syndrome. Differential diagnostic aspects in a case of well-differentiated malignant histiocytosis.

E. Kaiserling, H. Horny, R. Inniger, 1988, Pathology, research and practice.

Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host

U. Koszinowski, H. Bühring, M. Reddehase, 1988, The Journal of experimental medicine.

The monoclonal antibody 11G7 recognizes a novel differentiation antigen expressed on hemopoietic precursor cells.

A. Saalmüller, H. Bühring, A. van Agthoven, 1991, Hybridoma.

Immunhistological Analysis of Myeloma Colony-Forming Units by a new Preservation Technique

C. Müller, F. Busch, 1985 .

Modulation of in vitro myelopoiesis by alloreactive T cell clones

P. Wernet, G. Pawelec, E. Schneider, 1986, Blut.

Long-term cultured adult human keratinocytes secrete granulocyte-macrophage colony-stimulating factor but not interleukin-3 after cytokine exposure in vitro.

B. Bonnekoh, C. Orfanos, M. Owsianowski, 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society.

Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma

U. Koszinowski, M. Reddehase, F. Busch, 1991, Journal of virology.

Relative cloning efficiencies and long-term propagation capacity for T cell clones of highly purified natural interleukin 2 compared to recombinant interleukin 2 in man.

P. Wernet, G. Pawelec, A. Rehbein, 1987, Immunobiology.

Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia.

J. Schlessinger, B. Bossenmaier, H. Kalbacher, 1993, Cancer research.

IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-alpha.

G. Pawelec, A. Rehbein, K. Schaudt, 1989, Journal of immunology.

Frequencies of HLA-DP alleles in the four major types of leukaemia.

G. Pawelec, A. Rehbein, K. Schaudt, 1989, Tissue Antigens.

"Tolerization" of human T-helper cell clones by chronic exposure to alloantigen: culture conditions dictate autocrine proliferative status but not acquisition of cytotoxic potential and suppressor-induction capacity.

P. Wernet, G. Pawelec, T. Brocker, 1988, The Journal of molecular and cellular immunology : JMCI.